Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01933932
Brief Title: Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC (SELECT-1)

First Submitted : August 29, 2013
First Submitted that Met QC Criteria : August 29, 2013
First Posted : September 2, 2013 (Estimate)

Results First Submitted : February 27, 2017
Results First Submitted that Met QC Criteria : August 28, 2017
Results First Posted : August 29, 2017

Last Update Submitted that Met QC Criteria : September 18, 2019
Last Update Posted : September 19, 2019